Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical)

v3.25.3
CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical)
$ in Thousands
Sep. 30, 2025
USD ($)
firm
Dec. 31, 2024
USD ($)
firm
Investment Holding [Line Items]    
Investment, basis spread, variable rate 7.25% 7.50%
Aggregate gross unrealized appreciation $ 123,100 $ 108,400
Aggregate gross unrealized depreciation 108,100 156,500
Net unrealized appreciation (depreciation) over cost for U.S. federal income tax purposes 15,000 (48,100)
Aggregate cost of securities for U.S. federal income tax purposes (in billions) 4,300,000 3,700,000
Investment cost 4,290,863 [1] 3,708,877
Investments, at fair value: $ 4,306,154 $ 3,659,978
Contingent earn out payment receivable (as a percent) 12.48%  
1-month SOFR    
Investment Holding [Line Items]    
Interest rate 4.13% 4.33%
3-month SOFR    
Investment Holding [Line Items]    
Interest rate 3.98% 4.31%
6-month SOFR    
Investment Holding [Line Items]    
Interest rate 3.85% 4.25%
Common Stock | Significant Other Observable Inputs (Level 2)    
Investment Holding [Line Items]    
Number of publicly traded companies | firm 30 28
Warrants | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Investment Holding [Line Items]    
Number of publicly traded companies | firm 18 23
Black Crow AI, Inc. affiliates | Promissory Note    
Investment Holding [Line Items]    
Principal amount $ 2,800 $ 2,400
Akero Therapeutics, Inc. | Royalty Contract    
Investment Holding [Line Items]    
Investment cost 11,700 11,900
Investments, at fair value: $ 11,800 $ 11,600
[1] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized appreciation for federal income tax purposes totaled $123.1 million, $108.1 million and $15.0 million, respectively. The tax cost of investments is $4.3 billion